Theravance Biopharma Inc. (TBPH) NASDAQ
$8.96 (0.05) (-0.56%)
Market Cap: $433.96M
As of 03/28/24 03:59 PM EDT. Market closed.
Theravance Biopharma Inc. (TBPH)
NASDAQ
$8.96
(0.05) (-0.56%)
Market Cap: $433.96M
As of 03/28/24 03:59 PM EDT. Market closed.
theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical ... read more
theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Mar 15, 2024 | Option Exercise | $8.64 | 2,704 | 23,363 | 1,561,473 | Mar 19, 2024, 06:06 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 20, 2024 | Option Exercise | $8.92 | 37,196 | 331,788 | 1,558,769 | Feb 22, 2024, 08:14 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Feb 20, 2024 | Option Exercise | $8.92 | 17,036 | 151,961 | 238,636 | Feb 22, 2024, 08:11 PM |
Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Feb 20, 2024 | Option Exercise | $8.92 | 11,782 | 105,095 | 133,534 | Feb 22, 2024, 08:10 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Feb 20, 2024 | Option Exercise | $8.92 | 17,595 | 156,947 | 260,684 | Feb 22, 2024, 08:08 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Feb 20, 2024 | Option Exercise | $8.92 | 19,294 | 172,102 | 314,915 | Feb 22, 2024, 08:06 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 20, 2024 | Option Exercise | $8.92 | 18,219 | 162,513 | 312,987 | Feb 22, 2024, 08:04 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 22, 2024 | Sale | $8.71 | 1,254 | 10,922 | 311,733 | Feb 22, 2024, 08:04 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 20, 2023 | Option Exercise | $10.37 | 15,804 | 163,887 | 1,595,965 | Nov 22, 2023, 06:16 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Nov 20, 2023 | Option Exercise | $10.37 | 6,187 | 64,159 | 255,672 | Nov 22, 2023, 06:14 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Nov 20, 2023 | Option Exercise | $10.37 | 7,363 | 76,354 | 278,279 | Nov 22, 2023, 06:11 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 20, 2023 | Option Exercise | $10.37 | 12,630 | 130,973 | 334,209 | Nov 22, 2023, 06:10 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 20, 2023 | Option Exercise | $10.37 | 7,982 | 82,773 | 332,584 | Nov 22, 2023, 06:07 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 21, 2023 | Sale | $10.29 | 1,378 | 14,180 | 331,206 | Nov 22, 2023, 06:07 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 14, 2023 | Sale | $10.22 | 2,482 | 25,366 | 346,839 | Nov 16, 2023, 06:16 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Oct 16, 2023 | Sale | $9.03 | 2,482 | 22,412 | 334,321 | Oct 18, 2023, 06:54 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Sep 14, 2023 | Sale | $9.89 | 2,482 | 24,547 | 336,803 | Sep 18, 2023, 06:08 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 22, 2023 | Sale | $9.47 | 1,807 | 17,112 | 340,566 | Aug 24, 2023, 06:05 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Aug 20, 2023 | Option Exercise | $9.70 | 15,804 | 153,299 | 1,611,769 | Aug 22, 2023, 06:19 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Aug 20, 2023 | Option Exercise | $9.70 | 7,114 | 69,006 | 261,859 | Aug 22, 2023, 06:17 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Aug 20, 2023 | Option Exercise | $9.70 | 8,912 | 86,446 | 285,297 | Aug 22, 2023, 06:15 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Aug 20, 2023 | Option Exercise | $9.70 | 10,461 | 101,472 | 339,285 | Aug 22, 2023, 06:13 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 20, 2023 | Option Exercise | $9.70 | 10,460 | 101,462 | 342,373 | Aug 22, 2023, 06:10 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Aug 11, 2023 | Sale | $9.99 | 2,322 | 23,197 | 349,746 | Aug 15, 2023, 06:09 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Jul 14, 2023 | Sale | $9.84 | 2,322 | 22,848 | 352,068 | Jul 18, 2023, 06:14 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Jun 14, 2023 | Sale | $10.69 | 2,322 | 24,822 | 354,390 | Jun 16, 2023, 06:14 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Jun 08, 2023 | Sale | $11.13 | 1,790 | 19,923 | 352,833 | Jun 12, 2023, 06:08 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | May 20, 2023 | Option Exercise | $11.21 | 15,804 | 177,163 | 1,627,573 | May 23, 2023, 07:48 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | May 20, 2023 | Option Exercise | $11.21 | 8,744 | 98,020 | 268,973 | May 23, 2023, 07:46 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | May 20, 2023 | Option Exercise | $11.21 | 11,469 | 128,567 | 294,209 | May 23, 2023, 07:44 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | May 20, 2023 | Option Exercise | $11.21 | 10,460 | 117,257 | 356,712 | May 23, 2023, 07:41 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 20, 2023 | Option Exercise | $11.21 | 5,567 | 62,406 | 354,623 | May 23, 2023, 07:40 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | May 15, 2023 | Sale | $11.26 | 2,322 | 26,146 | 367,172 | May 17, 2023, 06:17 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Apr 14, 2023 | Sale | $11.88 | 2,323 | 27,597 | 369,494 | Apr 18, 2023, 05:49 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Mar 14, 2023 | Sale | $10.32 | 2,323 | 23,973 | 371,817 | Mar 16, 2023, 07:04 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Mar 09, 2023 | Sale | $10.20 | 4,000 | 40,800 | 360,190 | Mar 13, 2023, 05:57 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Mar 06, 2023 | Sale | $10.05 | 2,323 | 23,346 | 374,140 | Mar 08, 2023, 07:34 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 20, 2023 | Option Exercise | $10.44 | 37,420 | 390,665 | 1,313,377 | Feb 22, 2023, 07:29 PM |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Feb 20, 2023 | Option Exercise | $10.44 | 6,783 | 70,815 | 197,717 | Feb 22, 2023, 07:27 PM |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Feb 20, 2023 | Option Exercise | $10.44 | 10,198 | 106,467 | 229,958 | Feb 22, 2023, 07:23 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Feb 20, 2023 | Option Exercise | $10.44 | 12,057 | 125,875 | 301,463 | Feb 22, 2023, 07:21 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 20, 2023 | Option Exercise | $10.44 | 7,119 | 74,322 | 289,190 | Feb 22, 2023, 07:18 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Dec 14, 2022 | Sale | $11.19 | 50,000 | 559,500 | 1,350,797 | Dec 16, 2022, 07:36 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Dec 01, 2022 | Sale | $10.73 | 2,084 | 22,361 | 313,520 | Dec 05, 2022, 05:59 PM |
O'Connor Donal | Director | Nov 22, 2022 | Option Exercise | $10.50 | 10,000 | 105,000 | 43,886 | Nov 23, 2022, 06:57 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 20, 2022 | Option Exercise | $10.85 | 15,804 | 171,473 | 1,409,797 | Nov 22, 2022, 04:09 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 20, 2022 | Option Exercise | $10.85 | 25,057 | 271,868 | 384,714 | Nov 22, 2022, 04:07 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 18, 2022 | Sale | $11.02 | 65,000 | 716,242 | 409,771 | Nov 22, 2022, 04:07 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 20, 2022 | Option Exercise | $10.85 | 27,350 | 296,748 | 315,604 | Nov 22, 2022, 04:04 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Nov 20, 2022 | Option Exercise | $10.85 | 23,268 | 252,458 | 296,309 | Nov 22, 2022, 04:02 PM |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | Nov 16, 2022 | Option Exercise | $11.20 | 2,800 | 31,360 | 342,954 | Nov 17, 2022, 07:53 PM |
GSK PLC | Former 10% Owner | Sep 16, 2022 | Option Exercise | $9.75 | 9,644,807 | 94,036,868 | 0 | Sep 20, 2022, 04:16 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Aug 19, 2022 | Option Exercise | $9.34 | 15,804 | 147,609 | 1,424,784 | Aug 23, 2022, 07:03 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Aug 19, 2022 | Option Exercise | $9.34 | 25,676 | 239,814 | 473,507 | Aug 23, 2022, 07:00 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 19, 2022 | Option Exercise | $9.34 | 18,991 | 177,376 | 345,754 | Aug 23, 2022, 06:57 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Aug 19, 2022 | Option Exercise | $9.34 | 10,413 | 97,257 | 319,577 | Aug 23, 2022, 06:54 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 16, 2022 | Sale | $9.71 | 4,906 | 47,640 | 364,745 | Aug 18, 2022, 06:05 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Aug 09, 2022 | Sale | $8.79 | 15,086 | 132,606 | 369,651 | Aug 11, 2022, 06:55 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | May 20, 2022 | Option Exercise | $8.74 | 11,025 | 96,358 | 1,440,588 | May 24, 2022, 07:19 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | May 20, 2022 | Option Exercise | $8.74 | 3,365 | 29,410 | 479,183 | May 24, 2022, 07:17 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | May 20, 2022 | Option Exercise | $8.74 | 3,947 | 34,497 | 384,737 | May 24, 2022, 07:14 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 20, 2022 | Option Exercise | $8.74 | 2,200 | 19,228 | 331,071 | May 24, 2022, 07:11 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | May 23, 2022 | Sale | $8.93 | 1,081 | 9,653 | 329,990 | May 24, 2022, 07:11 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 28, 2022 | Sale | $10.16 | 2,356 | 23,947 | 333,271 | Mar 02, 2022, 07:08 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Feb 18, 2022 | Option Exercise | $9.61 | 22,710 | 218,243 | 1,279,300 | Feb 23, 2022, 06:38 PM |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | Feb 18, 2022 | Option Exercise | $9.61 | 27,299 | 262,343 | 380,123 | Feb 23, 2022, 06:34 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Feb 18, 2022 | Option Exercise | $9.61 | 25,973 | 249,601 | 481,285 | Feb 23, 2022, 06:29 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Feb 18, 2022 | Option Exercise | $9.61 | 20,377 | 195,823 | 388,684 | Feb 23, 2022, 06:25 PM |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Feb 18, 2022 | Option Exercise | $9.61 | 11,824 | 113,629 | 335,627 | Feb 23, 2022, 06:22 PM |
BRADY ANN | PRESIDENT, TBIL | Feb 18, 2022 | Option Exercise | $9.61 | 8,369 | 80,426 | 110,319 | Feb 23, 2022, 06:18 PM |
BRADY ANN | PRESIDENT, TBIL | Nov 19, 2021 | Option Exercise | $8.36 | 3,169 | 26,493 | 118,688 | Nov 23, 2021, 08:26 PM |
PASQUALONE FRANK | SVP, CHIEF BUSINESS OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 3,779 | 31,592 | 429,783 | Nov 23, 2021, 08:25 PM |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | Nov 19, 2021 | Option Exercise | $8.36 | 4,310 | 36,032 | 355,422 | Nov 23, 2021, 08:24 PM |
GRAHAM RICHARD A | SVP, DEVELOPMENT | Nov 19, 2021 | Option Exercise | $8.36 | 4,263 | 35,639 | 169,061 | Nov 23, 2021, 08:23 PM |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 1,350 | 11,286 | 167,258 | Nov 23, 2021, 08:22 PM |
WORBOYS PHILIP D | SVP, RESEARCH & TRANSL SCIENCE | Nov 19, 2021 | Option Exercise | $8.36 | 4,310 | 36,032 | 330,752 | Nov 23, 2021, 08:21 PM |
SABESAN VIJAY | SVP, TECHNICAL OPERATIONS | Nov 19, 2021 | Option Exercise | $8.36 | 5,191 | 43,397 | 235,524 | Nov 23, 2021, 08:21 PM |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | Nov 19, 2021 | Option Exercise | $8.36 | 11,404 | 95,337 | 1,302,010 | Nov 23, 2021, 08:20 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 335,062 | Aug 24, 2021, 07:07 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2021 | Option Exercise | $14.05 | 11,404 | 160,226 | 1,313,414 | Aug 24, 2021, 07:05 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 277,831 | Aug 24, 2021, 07:03 PM |
SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2021 | Option Exercise | $14.05 | 5,193 | 72,962 | 240,715 | Aug 24, 2021, 07:01 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2021 | Option Exercise | $14.05 | 4,307 | 60,513 | 359,732 | Aug 24, 2021, 06:59 PM |
PASQUALONE FRANK | SVP, Chief Business Officer | Aug 20, 2021 | Option Exercise | $14.05 | 3,779 | 53,095 | 433,562 | Aug 24, 2021, 06:57 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Aug 20, 2021 | Option Exercise | $14.05 | 17,464 | 245,369 | 167,380 | Aug 24, 2021, 06:55 PM |
GRAHAM RICHARD A | SVP, Development | Aug 20, 2021 | Option Exercise | $14.05 | 6,819 | 95,807 | 173,205 | Aug 24, 2021, 06:52 PM |
BRADY ANN | President, TBIL | Aug 20, 2021 | Option Exercise | $14.05 | 3,169 | 44,524 | 121,857 | Aug 24, 2021, 06:50 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2021 | Option Exercise | $17.80 | 11,404 | 202,991 | 1,324,818 | May 24, 2021, 06:19 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2021 | Option Exercise | $17.80 | 4,310 | 76,718 | 282,138 | May 24, 2021, 06:18 PM |
GRAHAM RICHARD A | SVP, Development | May 20, 2021 | Option Exercise | $17.80 | 3,410 | 60,698 | 180,024 | May 24, 2021, 06:09 PM |
BRADY ANN | President, TBIL | May 20, 2021 | Option Exercise | $17.80 | 3,169 | 56,408 | 125,026 | May 24, 2021, 06:07 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Mar 09, 2021 | Sale | $20.00 | 8,829 | 176,580 | 343,679 | Mar 11, 2021, 07:00 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Feb 20, 2021 | Option Exercise | $18.79 | 31,887 | 599,157 | 352,508 | Feb 23, 2021, 06:20 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2021 | Option Exercise | $18.79 | 110,348 | 2,073,439 | 1,334,821 | Feb 23, 2021, 06:17 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2021 | Option Exercise | $18.79 | 31,869 | 598,819 | 285,047 | Feb 23, 2021, 06:15 PM |
SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2021 | Option Exercise | $18.79 | 8,343 | 156,765 | 249,701 | Feb 23, 2021, 06:13 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2021 | Option Exercise | $18.79 | 31,931 | 599,984 | 368,349 | Feb 23, 2021, 06:10 PM |
PASQUALONE FRANK | SVP, Chief Business Officer | Feb 20, 2021 | Option Exercise | $18.79 | 26,961 | 506,597 | 439,719 | Feb 23, 2021, 06:09 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Feb 20, 2021 | Option Exercise | $18.79 | 3,984 | 74,859 | 184,704 | Feb 23, 2021, 06:07 PM |
HAUMANN BRETT K | Chief Medical Officer | Feb 20, 2021 | Option Exercise | $18.79 | 35,672 | 670,277 | 242,499 | Feb 23, 2021, 06:05 PM |
GRAHAM RICHARD A | SVP, Development | Feb 20, 2021 | Option Exercise | $18.79 | 6,597 | 123,958 | 182,152 | Feb 23, 2021, 06:03 PM |
BRADY ANN | President, TBIL | Feb 20, 2021 | Option Exercise | $18.79 | 10,092 | 189,629 | 128,195 | Feb 23, 2021, 06:01 PM |
GRAHAM RICHARD A | SVP, Development | Dec 14, 2020 | Sale | $19.47 | 7,500 | 146,058 | 123,749 | Dec 16, 2020, 06:09 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Dec 03, 2020 | Sale | $18.00 | 4,246 | 76,428 | 319,395 | Dec 07, 2020, 06:42 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Nov 20, 2020 | Option Exercise | $17.21 | 4,807 | 82,728 | 323,641 | Nov 24, 2020, 06:25 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2020 | Option Exercise | $17.21 | 13,946 | 240,011 | 1,275,169 | Nov 24, 2020, 06:24 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2020 | Option Exercise | $17.21 | 4,807 | 82,728 | 251,916 | Nov 24, 2020, 06:22 PM |
SABESAN VIJAY | SVP, Technical Operations | Nov 20, 2020 | Option Exercise | $17.21 | 3,798 | 65,364 | 193,044 | Nov 24, 2020, 06:21 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2020 | Option Exercise | $17.21 | 4,807 | 82,728 | 335,280 | Nov 24, 2020, 06:19 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2020 | Option Exercise | $17.21 | 4,214 | 72,523 | 401,680 | Nov 24, 2020, 06:17 PM |
HAUMANN BRETT K | Chief Medical Officer | Nov 20, 2020 | Option Exercise | $17.21 | 4,639 | 79,837 | 278,171 | Nov 24, 2020, 06:16 PM |
GRAHAM RICHARD A | SVP, Development | Nov 20, 2020 | Option Exercise | $17.21 | 3,876 | 66,706 | 131,249 | Nov 24, 2020, 06:14 PM |
BRADY ANN | President, TBIL | Nov 20, 2020 | Option Exercise | $17.21 | 2,292 | 39,445 | 98,287 | Nov 24, 2020, 06:13 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2020 | Option Exercise | $18.22 | 4,804 | 87,529 | 328,448 | Aug 24, 2020, 06:38 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Aug 20, 2020 | Sale | $18.00 | 17,103 | 307,854 | 333,252 | Aug 24, 2020, 06:38 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2020 | Option Exercise | $18.22 | 13,946 | 254,096 | 1,289,115 | Aug 24, 2020, 06:36 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2020 | Option Exercise | $18.22 | 4,804 | 87,529 | 256,723 | Aug 24, 2020, 06:34 PM |
SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2020 | Option Exercise | $18.22 | 3,799 | 69,218 | 196,842 | Aug 24, 2020, 06:32 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2020 | Option Exercise | $18.22 | 4,804 | 87,529 | 340,087 | Aug 24, 2020, 06:29 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,214 | 76,779 | 405,894 | Aug 24, 2020, 06:27 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,323 | 78,765 | 123,135 | Aug 24, 2020, 06:24 PM |
HAUMANN BRETT K | Chief Medical Officer | Aug 20, 2020 | Option Exercise | $18.22 | 4,646 | 84,650 | 307,810 | Aug 24, 2020, 06:21 PM |
HAUMANN BRETT K | Chief Medical Officer | Aug 21, 2020 | Sale | $18.29 | 25,000 | 457,240 | 282,810 | Aug 24, 2020, 06:21 PM |
GRAHAM RICHARD A | SVP, Development | Aug 20, 2020 | Option Exercise | $18.22 | 6,598 | 120,216 | 107,625 | Aug 24, 2020, 06:20 PM |
BRADY ANN | President, TBIL | Aug 20, 2020 | Option Exercise | $18.22 | 2,292 | 41,760 | 100,579 | Aug 24, 2020, 06:19 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | May 20, 2020 | Option Exercise | $26.67 | 4,807 | 128,203 | 350,355 | May 22, 2020, 06:14 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2020 | Option Exercise | $26.67 | 13,946 | 371,940 | 1,303,061 | May 22, 2020, 06:13 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2020 | Option Exercise | $26.67 | 4,807 | 128,203 | 261,527 | May 22, 2020, 06:11 PM |
SABESAN VIJAY | SVP, Technical Operations | May 20, 2020 | Option Exercise | $26.67 | 3,801 | 101,373 | 200,641 | May 22, 2020, 06:10 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2020 | Option Exercise | $26.67 | 4,807 | 128,203 | 344,891 | May 22, 2020, 06:09 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2020 | Option Exercise | $26.67 | 4,214 | 112,387 | 410,108 | May 22, 2020, 06:07 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2020 | Option Exercise | $26.67 | 4,212 | 112,334 | 312,456 | May 22, 2020, 06:06 PM |
BRADY ANN | President, TBIL | May 20, 2020 | Option Exercise | $26.67 | 2,292 | 61,128 | 102,871 | May 22, 2020, 06:05 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Feb 20, 2020 | Option Exercise | $25.90 | 29,105 | 753,819 | 354,750 | Feb 24, 2020, 07:16 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2020 | Option Exercise | $25.90 | 96,850 | 2,508,415 | 1,315,605 | Feb 24, 2020, 07:15 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2020 | Option Exercise | $25.90 | 29,402 | 761,512 | 264,932 | Feb 24, 2020, 07:13 PM |
SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2020 | Option Exercise | $25.90 | 7,213 | 186,817 | 203,040 | Feb 24, 2020, 07:12 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2020 | Option Exercise | $25.90 | 29,136 | 754,622 | 349,698 | Feb 24, 2020, 07:11 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Feb 20, 2020 | Option Exercise | $25.90 | 24,392 | 631,753 | 412,920 | Feb 24, 2020, 07:10 PM |
Hindman Andrew A. | SVP, Chief Financial Officer | Feb 20, 2020 | Option Exercise | $25.90 | 7,060 | 182,854 | 106,490 | Feb 24, 2020, 07:08 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2020 | Option Exercise | $25.90 | 33,608 | 870,447 | 316,668 | Feb 24, 2020, 07:07 PM |
BRADY ANN | President, TBIL | Feb 20, 2020 | Option Exercise | $25.90 | 5,948 | 154,053 | 105,163 | Feb 24, 2020, 07:05 PM |
SABESAN VIJAY | SVP, Technical Operations | Dec 12, 2019 | Sale | $21.03 | 1,027 | 21,598 | 145,253 | Dec 16, 2019, 06:09 PM |
WORBOYS PHILIP D | SVP, Research & Transl Science | Nov 20, 2019 | Option Exercise | $17.60 | 2,272 | 39,987 | 264,855 | Nov 22, 2019, 06:28 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2019 | Option Exercise | $17.60 | 8,678 | 152,733 | 1,074,455 | Nov 22, 2019, 06:26 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2019 | Option Exercise | $17.60 | 3,567 | 62,779 | 175,334 | Nov 22, 2019, 06:25 PM |
SABESAN VIJAY | SVP, Technical Operations | Nov 20, 2019 | Option Exercise | $17.60 | 1,473 | 25,925 | 146,280 | Nov 22, 2019, 06:24 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2019 | Option Exercise | $17.60 | 2,272 | 39,987 | 259,834 | Nov 22, 2019, 06:23 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2019 | Option Exercise | $17.60 | 2,447 | 43,067 | 318,312 | Nov 22, 2019, 06:22 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2019 | Option Exercise | $17.60 | 2,692 | 47,379 | 231,276 | Nov 22, 2019, 06:20 PM |
BRADY ANN | President, TBIL | Nov 20, 2019 | Option Exercise | $17.60 | 1,073 | 18,885 | 71,111 | Nov 22, 2019, 06:18 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 267,127 | Aug 22, 2019, 06:08 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2019 | Option Exercise | $21.51 | 8,678 | 186,664 | 1,083,133 | Aug 22, 2019, 06:07 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2019 | Option Exercise | $21.51 | 3,084 | 66,337 | 178,901 | Aug 22, 2019, 06:06 PM |
SABESAN VIJAY | SVP, Technical Operations | Aug 20, 2019 | Option Exercise | $21.51 | 1,472 | 31,663 | 147,753 | Aug 22, 2019, 06:05 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 262,106 | Aug 22, 2019, 06:03 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2019 | Option Exercise | $21.51 | 2,335 | 50,226 | 320,759 | Aug 22, 2019, 06:02 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2019 | Option Exercise | $21.51 | 2,272 | 48,871 | 259,900 | Aug 22, 2019, 06:01 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2019 | Option Exercise | $21.51 | 2,710 | 58,292 | 233,968 | Aug 22, 2019, 06:00 PM |
BRADY ANN | President, TBIL | Aug 20, 2019 | Option Exercise | $21.51 | 1,073 | 23,080 | 72,184 | Aug 22, 2019, 05:58 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 269,399 | May 22, 2019, 06:19 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2019 | Option Exercise | $19.84 | 8,678 | 172,172 | 1,091,811 | May 22, 2019, 06:17 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2019 | Option Exercise | $19.84 | 2,488 | 49,362 | 181,985 | May 22, 2019, 06:15 PM |
SABESAN VIJAY | SVP, Technical Operations | May 20, 2019 | Option Exercise | $19.84 | 1,474 | 29,244 | 149,225 | May 22, 2019, 06:13 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 264,378 | May 22, 2019, 06:11 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2019 | Option Exercise | $19.84 | 1,604 | 31,823 | 323,094 | May 22, 2019, 06:09 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2019 | Option Exercise | $19.84 | 2,272 | 45,076 | 262,172 | May 22, 2019, 06:07 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2019 | Option Exercise | $19.84 | 2,705 | 53,667 | 236,678 | May 22, 2019, 06:05 PM |
BRADY ANN | President, TBIL | May 20, 2019 | Option Exercise | $19.84 | 1,073 | 21,288 | 73,257 | May 22, 2019, 06:03 PM |
O'Connor Donal | Director | May 16, 2019 | Sale | $21.00 | 1,327 | 27,867 | 30,244 | May 20, 2019, 06:02 PM |
O'Connor Donal | Director | May 17, 2019 | Sale | $20.19 | 2,673 | 53,968 | 27,571 | May 20, 2019, 06:02 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Mar 05, 2019 | Sale | $24.50 | 5,690 | 139,405 | 264,444 | Mar 06, 2019, 07:20 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Mar 04, 2019 | Sale | $25.06 | 3,343 | 83,764 | 270,134 | Mar 06, 2019, 07:20 PM |
WORBOYS PHILIP D | SVP, Translational Science | Feb 20, 2019 | Option Exercise | $27.00 | 3,986 | 107,622 | 270,644 | Feb 22, 2019, 06:27 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2019 | Option Exercise | $27.00 | 13,477 | 363,879 | 1,099,462 | Feb 22, 2019, 06:25 PM |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | Feb 20, 2019 | Option Exercise | $27.00 | 5,763 | 155,601 | 97,198 | Feb 22, 2019, 06:23 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2019 | Option Exercise | $27.00 | 5,798 | 156,546 | 183,446 | Feb 22, 2019, 06:22 PM |
SABESAN VIJAY | SVP, Technical Operations | Feb 20, 2019 | Option Exercise | $27.00 | 4,568 | 123,336 | 149,672 | Feb 22, 2019, 06:20 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2019 | Option Exercise | $27.00 | 3,674 | 99,198 | 266,650 | Feb 22, 2019, 06:18 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Feb 20, 2019 | Option Exercise | $27.00 | 4,919 | 132,813 | 323,671 | Feb 22, 2019, 06:16 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2019 | Option Exercise | $27.00 | 3,770 | 101,790 | 273,477 | Feb 22, 2019, 06:15 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2019 | Option Exercise | $27.00 | 7,778 | 210,006 | 239,383 | Feb 22, 2019, 06:13 PM |
BRADY ANN | President, TBIL | Feb 20, 2019 | Option Exercise | $27.00 | 3,023 | 81,621 | 74,330 | Feb 22, 2019, 06:11 PM |
WORBOYS PHILIP D | SVP, Translational Science | Nov 20, 2018 | Option Exercise | $24.79 | 4,373 | 108,407 | 162,380 | Nov 21, 2018, 05:48 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2018 | Option Exercise | $24.79 | 15,557 | 385,658 | 795,939 | Nov 21, 2018, 05:47 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2018 | Option Exercise | $24.79 | 7,006 | 173,679 | 76,994 | Nov 21, 2018, 05:46 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2018 | Option Exercise | $24.79 | 3,908 | 96,879 | 158,074 | Nov 21, 2018, 05:45 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2018 | Option Exercise | $24.79 | 5,735 | 142,171 | 216,340 | Nov 21, 2018, 05:45 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2018 | Option Exercise | $24.79 | 4,063 | 100,722 | 164,997 | Nov 21, 2018, 05:44 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2018 | Option Exercise | $24.79 | 7,368 | 182,653 | 134,911 | Nov 21, 2018, 05:43 PM |
GALA RENEE D | SVP, Chief Financial Officer | Nov 20, 2018 | Option Exercise | $24.79 | 6,697 | 166,019 | 157,657 | Nov 21, 2018, 05:42 PM |
WORBOYS PHILIP D | SVP, Translational Science | Sep 12, 2018 | Sale | $28.50 | 6,393 | 182,201 | 166,753 | Sep 14, 2018, 05:03 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 27, 2018 | Sale | $27.71 | 7,119 | 197,282 | 84,000 | Aug 29, 2018, 06:24 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2018 | Option Exercise | $26.95 | 5,508 | 148,441 | 173,146 | Aug 22, 2018, 07:35 PM |
Winningham Rick E | Chief Executive Officer | Aug 20, 2018 | Option Exercise | $26.95 | 15,557 | 419,261 | 904,063 | Aug 22, 2018, 07:35 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2018 | Option Exercise | $26.95 | 7,005 | 188,785 | 91,119 | Aug 22, 2018, 07:34 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2018 | Option Exercise | $26.95 | 5,043 | 135,909 | 161,982 | Aug 22, 2018, 07:34 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2018 | Option Exercise | $26.95 | 5,735 | 154,558 | 222,075 | Aug 22, 2018, 07:33 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2018 | Option Exercise | $26.95 | 5,198 | 140,086 | 169,060 | Aug 22, 2018, 07:33 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2018 | Option Exercise | $26.95 | 6,683 | 180,107 | 142,279 | Aug 22, 2018, 07:33 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 20, 2018 | Option Exercise | $26.95 | 6,695 | 180,430 | 164,354 | Aug 22, 2018, 07:32 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 15, 2018 | Sale | $26.74 | 41,539 | 1,110,655 | 172,749 | Aug 16, 2018, 07:08 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 14, 2018 | Sale | $27.74 | 2,204 | 61,136 | 212,588 | Aug 16, 2018, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 08, 2018 | Sale | $27.85 | 25,355 | 706,182 | 98,124 | Aug 09, 2018, 07:46 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 07, 2018 | Sale | $28.33 | 5,945 | 168,393 | 127,606 | Aug 09, 2018, 07:46 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Jun 08, 2018 | Sale | $23.66 | 3,900 | 92,260 | 129,424 | Jun 08, 2018, 07:34 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Jun 06, 2018 | Sale | $24.09 | 10,140 | 244,268 | 133,324 | Jun 08, 2018, 07:34 PM |
MALKIEL BURTON G | Director | May 21, 2018 | Buy | $22.54 | 1,000 | 22,540 | 56,757 | May 23, 2018, 06:49 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2018 | Option Exercise | $24.31 | 19,524 | 474,628 | 178,654 | May 22, 2018, 07:03 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2018 | Option Exercise | $24.31 | 67,617 | 1,643,769 | 919,620 | May 22, 2018, 07:03 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2018 | Option Exercise | $24.31 | 21,812 | 530,250 | 143,464 | May 22, 2018, 07:02 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2018 | Option Exercise | $24.31 | 18,779 | 456,517 | 167,025 | May 22, 2018, 07:02 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2018 | Option Exercise | $24.31 | 18,424 | 447,887 | 227,810 | May 22, 2018, 07:02 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2018 | Option Exercise | $24.31 | 19,103 | 464,394 | 174,258 | May 22, 2018, 07:01 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2018 | Option Exercise | $24.31 | 26,991 | 656,151 | 148,962 | May 22, 2018, 07:01 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 20, 2018 | Option Exercise | $24.31 | 21,230 | 516,101 | 214,792 | May 22, 2018, 07:01 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 18, 2018 | Sale | $24.29 | 10,000 | 242,877 | 236,022 | May 22, 2018, 07:01 PM |
WORBOYS PHILIP D | SVP, Translational Science | Feb 20, 2018 | Option Exercise | $29.09 | 4,566 | 132,825 | 163,563 | Feb 22, 2018, 05:42 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2018 | Option Exercise | $29.09 | 13,005 | 378,315 | 881,372 | Feb 22, 2018, 05:42 PM |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | Feb 20, 2018 | Option Exercise | $29.09 | 8,770 | 255,119 | 101,230 | Feb 22, 2018, 05:41 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2018 | Option Exercise | $29.09 | 5,587 | 162,526 | 130,661 | Feb 22, 2018, 05:41 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2018 | Option Exercise | $29.09 | 4,252 | 123,691 | 152,054 | Feb 22, 2018, 05:40 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Feb 20, 2018 | Option Exercise | $29.09 | 4,741 | 137,916 | 211,619 | Feb 22, 2018, 05:40 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2018 | Option Exercise | $29.09 | 4,349 | 126,512 | 159,611 | Feb 22, 2018, 05:39 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2018 | Option Exercise | $29.09 | 8,293 | 241,243 | 142,203 | Feb 22, 2018, 05:39 PM |
GALA RENEE D | SVP, Chief Financial Officer | Feb 20, 2018 | Option Exercise | $29.09 | 5,387 | 156,708 | 211,407 | Feb 22, 2018, 05:38 PM |
WORBOYS PHILIP D | SVP, Translational Science | Nov 20, 2017 | Option Exercise | $28.58 | 5,503 | 157,276 | 159,129 | Nov 22, 2017, 04:40 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2017 | Option Exercise | $28.58 | 7,079 | 202,318 | 127,248 | Nov 22, 2017, 04:40 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2017 | Option Exercise | $28.58 | 5,014 | 143,300 | 147,306 | Nov 22, 2017, 04:39 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Nov 20, 2017 | Option Exercise | $28.58 | 5,820 | 166,336 | 207,360 | Nov 22, 2017, 04:38 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2017 | Option Exercise | $28.58 | 5,177 | 147,959 | 154,960 | Nov 22, 2017, 04:38 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2017 | Option Exercise | $28.58 | 7,846 | 224,239 | 141,496 | Nov 22, 2017, 04:37 PM |
GALA RENEE D | SVP, Chief Financial Officer | Nov 20, 2017 | Option Exercise | $28.58 | 6,753 | 193,001 | 207,794 | Nov 22, 2017, 04:35 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Sep 06, 2017 | Sale | $30.77 | 14,670 | 451,350 | 134,327 | Sep 08, 2017, 06:53 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 21, 2017 | Buy | $26.34 | 4,000 | 105,359 | 213,180 | Aug 23, 2017, 05:04 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2017 | Option Exercise | $27.40 | 5,502 | 150,755 | 164,632 | Aug 22, 2017, 06:31 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2017 | Option Exercise | $27.40 | 7,079 | 193,965 | 148,997 | Aug 22, 2017, 06:30 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2017 | Option Exercise | $27.40 | 5,013 | 137,356 | 152,320 | Aug 22, 2017, 06:30 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | Aug 20, 2017 | Option Exercise | $27.40 | 5,820 | 159,468 | 209,180 | Aug 22, 2017, 06:29 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2017 | Option Exercise | $27.40 | 5,176 | 141,822 | 160,137 | Aug 22, 2017, 06:28 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2017 | Option Exercise | $27.40 | 7,064 | 193,554 | 149,342 | Aug 22, 2017, 06:28 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 20, 2017 | Option Exercise | $27.40 | 6,752 | 185,005 | 214,547 | Aug 22, 2017, 06:27 PM |
WHITESIDES GEORGE M | Director | Aug 11, 2017 | Buy | $24.69 | 4,000 | 98,764 | 4,000 | Aug 14, 2017, 08:00 PM |
MALKIEL BURTON G | Director | Aug 11, 2017 | Buy | $24.59 | 15,000 | 368,815 | 15,000 | Aug 14, 2017, 07:57 PM |
MALKIEL BURTON G | Director | Aug 11, 2017 | Buy | $24.59 | 15,000 | 368,854 | 47,571 | Aug 14, 2017, 07:57 PM |
Fore Henrietta | Director | Aug 11, 2017 | Buy | $23.99 | 6,000 | 143,932 | 24,000 | Aug 11, 2017, 06:33 PM |
Winningham Rick E | Chief Executive Officer | Aug 11, 2017 | Buy | $24.50 | 10,000 | 245,000 | 866,377 | Aug 11, 2017, 06:26 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2017 | Option Exercise | $36.83 | 5,503 | 202,676 | 170,134 | May 23, 2017, 08:01 PM |
Winningham Rick E | Chief Executive Officer | May 20, 2017 | Option Exercise | $36.83 | 15,460 | 569,392 | 856,377 | May 23, 2017, 08:01 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2017 | Option Exercise | $36.83 | 7,079 | 260,720 | 156,076 | May 23, 2017, 08:00 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2017 | Option Exercise | $36.83 | 5,014 | 184,666 | 157,333 | May 23, 2017, 08:00 PM |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | May 20, 2017 | Option Exercise | $36.83 | 5,820 | 214,351 | 215,000 | May 23, 2017, 08:00 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2017 | Option Exercise | $36.83 | 5,177 | 190,669 | 165,313 | May 23, 2017, 07:59 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2017 | Option Exercise | $36.83 | 7,065 | 260,204 | 156,406 | May 23, 2017, 07:59 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 20, 2017 | Option Exercise | $36.83 | 6,753 | 248,713 | 221,299 | May 23, 2017, 07:58 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Mar 07, 2017 | Sale | $30.80 | 424 | 13,059 | 163,471 | Mar 08, 2017, 06:11 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Mar 06, 2017 | Sale | $31.52 | 13,576 | 427,916 | 163,895 | Mar 08, 2017, 06:11 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Mar 03, 2017 | Sale | $31.86 | 26,829 | 854,772 | 161,453 | Mar 07, 2017, 07:05 PM |
WORBOYS PHILIP D | SVP, Translational Science | Feb 20, 2017 | Option Exercise | $33.78 | 10,397 | 351,211 | 173,935 | Feb 22, 2017, 07:08 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2017 | Option Exercise | $33.78 | 33,264 | 1,123,658 | 870,135 | Feb 22, 2017, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Feb 20, 2017 | Option Exercise | $33.78 | 12,440 | 420,223 | 188,282 | Feb 22, 2017, 07:07 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Feb 20, 2017 | Option Exercise | $33.78 | 10,030 | 338,813 | 162,347 | Feb 22, 2017, 07:07 PM |
PASQUALONE FRANK | SVP Global Head Acute Care Bus | Feb 20, 2017 | Option Exercise | $33.78 | 8,762 | 295,980 | 219,118 | Feb 22, 2017, 07:07 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2017 | Option Exercise | $33.78 | 9,611 | 324,660 | 225,071 | Feb 22, 2017, 07:06 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Feb 20, 2017 | Option Exercise | $33.78 | 10,138 | 342,462 | 170,490 | Feb 22, 2017, 07:06 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Feb 20, 2017 | Option Exercise | $33.78 | 14,434 | 487,581 | 177,471 | Feb 22, 2017, 07:06 PM |
GALA RENEE D | SVP, Chief Financial Officer | Feb 20, 2017 | Option Exercise | $33.78 | 10,211 | 344,928 | 226,350 | Feb 22, 2017, 07:05 PM |
WORBOYS PHILIP D | SVP, Translational Science | Nov 20, 2016 | Option Exercise | $31.96 | 2,104 | 67,244 | 175,332 | Nov 22, 2016, 06:07 PM |
Winningham Rick E | Chief Executive Officer | Nov 20, 2016 | Option Exercise | $31.96 | 8,360 | 267,186 | 875,399 | Nov 22, 2016, 06:06 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Nov 20, 2016 | Option Exercise | $31.96 | 4,008 | 128,096 | 191,722 | Nov 22, 2016, 06:04 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Nov 20, 2016 | Option Exercise | $31.96 | 1,727 | 55,195 | 163,377 | Nov 22, 2016, 06:04 PM |
LEE JUNNING | Sr. VP, Technical Operations | Nov 20, 2016 | Option Exercise | $31.96 | 3,785 | 120,969 | 234,682 | Nov 22, 2016, 06:03 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Nov 20, 2016 | Option Exercise | $31.96 | 1,845 | 58,966 | 171,628 | Nov 22, 2016, 06:03 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Nov 20, 2016 | Option Exercise | $31.96 | 5,388 | 172,200 | 182,905 | Nov 22, 2016, 06:02 PM |
GALA RENEE D | SVP, Chief Financial Officer | Nov 20, 2016 | Option Exercise | $31.96 | 4,628 | 147,911 | 227,561 | Nov 22, 2016, 06:01 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 25, 2016 | Sale | $27.99 | 4,491 | 125,703 | 188,293 | Aug 25, 2016, 07:34 PM |
WORBOYS PHILIP D | SVP, Translational Science | Aug 20, 2016 | Option Exercise | $27.89 | 2,104 | 58,681 | 177,436 | Aug 23, 2016, 07:26 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | Aug 20, 2016 | Option Exercise | $27.89 | 1,729 | 48,222 | 165,104 | Aug 23, 2016, 07:25 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 20, 2016 | Option Exercise | $27.89 | 3,785 | 105,564 | 238,467 | Aug 23, 2016, 07:24 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | Aug 20, 2016 | Option Exercise | $27.89 | 1,846 | 51,485 | 173,473 | Aug 23, 2016, 07:23 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 20, 2016 | Option Exercise | $27.89 | 4,607 | 128,489 | 192,784 | Aug 23, 2016, 07:23 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | Aug 19, 2016 | Sale | $27.97 | 9,509 | 265,967 | 197,391 | Aug 23, 2016, 07:23 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 20, 2016 | Option Exercise | $27.89 | 4,306 | 120,094 | 232,189 | Aug 23, 2016, 07:22 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 20, 2016 | Option Exercise | $27.89 | 4,008 | 111,783 | 232,808 | Aug 22, 2016, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 22, 2016 | Sale | $27.16 | 37,078 | 1,007,038 | 195,730 | Aug 22, 2016, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 19, 2016 | Sale | $28.14 | 4,870 | 137,042 | 236,816 | Aug 22, 2016, 07:08 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | Aug 18, 2016 | Sale | $28.55 | 7,174 | 204,818 | 241,686 | Aug 22, 2016, 07:08 PM |
WORBOYS PHILIP D | SVP, Translational Science | May 20, 2016 | Option Exercise | $20.55 | 2,105 | 43,258 | 179,540 | May 24, 2016, 08:01 PM |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | May 20, 2016 | Option Exercise | $20.55 | 4,008 | 82,364 | 248,860 | May 24, 2016, 08:00 PM |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | May 20, 2016 | Option Exercise | $20.55 | 1,728 | 35,510 | 166,833 | May 24, 2016, 08:00 PM |
LEE JUNNING | Sr. VP, Technical Operations | May 20, 2016 | Option Exercise | $20.55 | 3,785 | 77,782 | 242,252 | May 24, 2016, 07:59 PM |
HEGDE SHARATHCHANDRA S | SVP, Research | May 20, 2016 | Option Exercise | $20.55 | 1,846 | 37,935 | 175,319 | May 24, 2016, 07:59 PM |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | May 20, 2016 | Option Exercise | $20.55 | 4,608 | 94,694 | 206,900 | May 24, 2016, 07:59 PM |
GALA RENEE D | SVP, Chief Financial Officer | May 20, 2016 | Option Exercise | $20.55 | 3,333 | 68,493 | 236,495 | May 24, 2016, 07:58 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Mar 14, 2016 | Buy | $23028000.00 | 1,301,015 | 29,959,773,420,000 | 9,644,807 | Mar 15, 2016, 04:31 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2016 | Option Exercise | $15.65 | 18,920 | 296,098 | 136,165 | Feb 23, 2016, 07:59 PM |
GALA RENEE D | SVP, Chief Financial Officer | Feb 20, 2016 | Option Exercise | $15.65 | 13,052 | 204,264 | 148,125 | Feb 23, 2016, 07:58 PM |
Mammen Mathai | SVP, Research & Development | Feb 20, 2016 | Option Exercise | $15.65 | 19,844 | 310,559 | 198,111 | Feb 23, 2016, 07:58 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2016 | Option Exercise | $15.65 | 16,049 | 251,167 | 154,335 | Feb 23, 2016, 07:57 PM |
HAUMANN BRETT K | SVP, Clinical Development | Feb 20, 2016 | Option Exercise | $15.65 | 18,425 | 288,351 | 121,508 | Feb 23, 2016, 07:56 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Feb 20, 2016 | Option Exercise | $15.65 | 16,101 | 251,981 | 182,731 | Feb 23, 2016, 07:56 PM |
PASQUALONE FRANK | Sr. VP, Operations | Feb 20, 2016 | Option Exercise | $15.65 | 10,830 | 169,489 | 127,178 | Feb 23, 2016, 07:55 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Nov 20, 2015 | Option Exercise | $17.17 | 934 | 16,037 | 155,085 | Nov 24, 2015, 07:37 PM |
Mammen Mathai | SVP, Research & Development | Nov 20, 2015 | Option Exercise | $17.17 | 934 | 16,037 | 217,955 | Nov 24, 2015, 07:37 PM |
LEE JUNNING | Sr. VP, Technical Operations | Nov 20, 2015 | Option Exercise | $17.17 | 1,037 | 17,805 | 170,384 | Nov 24, 2015, 07:36 PM |
HAUMANN BRETT K | SVP, Clinical Development | Nov 20, 2015 | Option Exercise | $17.17 | 781 | 13,410 | 139,933 | Nov 24, 2015, 07:36 PM |
GLAXOSMITHKLINE PLC | 10% Owner | Oct 07, 2015 | Buy | $607544.00 | 44,574 | 27,080,666,256 | 8,343,792 | Oct 07, 2015, 04:31 PM |
Mammen Mathai | SVP, Research & Development | Aug 20, 2015 | Option Exercise | $12.98 | 934 | 12,123 | 218,889 | Aug 24, 2015, 07:11 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Aug 20, 2015 | Option Exercise | $12.98 | 934 | 12,123 | 198,832 | Aug 24, 2015, 07:11 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Aug 20, 2015 | Option Exercise | $12.98 | 934 | 12,123 | 156,019 | Aug 24, 2015, 07:10 PM |
LEE JUNNING | Sr. VP, Technical Operations | Aug 18, 2015 | Buy | $12.90 | 9,000 | 116,100 | 9,000 | Aug 18, 2015, 08:30 PM |
MALKIEL BURTON G | Director | Aug 18, 2015 | Buy | $12.92 | 10,000 | 129,200 | 20,571 | Aug 18, 2015, 08:26 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 17, 2015 | Buy | $12.16 | 5,000 | 60,800 | 161,177 | Aug 17, 2015, 07:21 PM |
GALA RENEE D | SVP, Chief Financial Officer | Aug 13, 2015 | Buy | $12.19 | 5,000 | 60,950 | 154,279 | Aug 17, 2015, 07:21 PM |
Winningham Rick E | Chief Executive Officer | Aug 17, 2015 | Buy | $12.13 | 16,860 | 204,512 | 602,056 | Aug 17, 2015, 07:21 PM |
Winningham Rick E | Chief Executive Officer | Aug 14, 2015 | Buy | $11.79 | 63,140 | 744,421 | 583,298 | Aug 17, 2015, 07:21 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Jun 02, 2015 | Option Exercise | $13.83 | 7,360 | 101,789 | 156,953 | Jun 04, 2015, 07:14 PM |
Mammen Mathai | SVP, Research & Development | Jun 02, 2015 | Option Exercise | $13.83 | 7,360 | 101,789 | 219,823 | Jun 04, 2015, 07:14 PM |
LEE JUNNING | Sr. VP, Technical Operations | Jun 02, 2015 | Option Exercise | $13.83 | 5,152 | 71,252 | 169,720 | Jun 04, 2015, 07:13 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Jun 02, 2015 | Option Exercise | $13.83 | 7,360 | 101,789 | 199,766 | Jun 04, 2015, 07:13 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | May 20, 2015 | Option Exercise | $14.24 | 673 | 9,584 | 164,313 | May 22, 2015, 07:16 PM |
LEE JUNNING | Sr. VP, Technical Operations | May 20, 2015 | Option Exercise | $14.24 | 748 | 10,652 | 174,872 | May 22, 2015, 07:16 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | May 20, 2015 | Option Exercise | $14.24 | 673 | 9,584 | 207,126 | May 22, 2015, 07:13 PM |
Mammen Mathai | SVP, Research & Development | May 20, 2015 | Option Exercise | $14.24 | 673 | 9,584 | 227,183 | May 22, 2015, 07:13 PM |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | Feb 20, 2015 | Option Exercise | $19.52 | 674 | 13,156 | 163,088 | Feb 24, 2015, 06:55 PM |
Mammen Mathai | SVP, Research & Development | Feb 20, 2015 | Option Exercise | $19.52 | 674 | 13,156 | 227,856 | Feb 24, 2015, 06:55 PM |
LEE JUNNING | Sr. VP, Technical Operations | Feb 20, 2015 | Option Exercise | $19.52 | 970 | 18,934 | 175,620 | Feb 24, 2015, 06:54 PM |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | Feb 20, 2015 | Option Exercise | $19.52 | 674 | 13,156 | 207,799 | Feb 24, 2015, 06:54 PM |
Winningham Rick E | Chief Executive Officer | Feb 20, 2015 | Option Exercise | $19.52 | 1,480 | 28,890 | 520,158 | Feb 24, 2015, 06:53 PM |
GALA RENEE D | SVP-Finance | Aug 20, 2014 | Option Exercise | $26.98 | 158 | 4,263 | 14,279 | Aug 22, 2014, 05:01 PM |
Owner | Relationship | Date | Value($) |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 03/15/2024 | 23,363 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 02/20/2024 | 331,788 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 02/20/2024 | 151,961 |
Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | 02/20/2024 | 105,095 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 02/20/2024 | 156,947 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 02/20/2024 | 172,102 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/20/2024 | 162,513 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/22/2024 | 10,922 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 11/20/2023 | 163,887 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 11/20/2023 | 64,159 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 11/20/2023 | 76,354 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/20/2023 | 130,973 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 11/20/2023 | 82,773 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 11/21/2023 | 14,180 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/14/2023 | 25,366 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 10/16/2023 | 22,412 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 09/14/2023 | 24,547 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 08/22/2023 | 17,112 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 08/20/2023 | 153,299 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 08/20/2023 | 69,006 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 08/20/2023 | 86,446 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 08/20/2023 | 101,472 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 08/20/2023 | 101,462 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 08/11/2023 | 23,197 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 07/14/2023 | 22,848 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 06/14/2023 | 24,822 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 06/08/2023 | 19,923 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 05/20/2023 | 177,163 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 05/20/2023 | 98,020 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 05/20/2023 | 128,567 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 05/20/2023 | 117,257 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 05/20/2023 | 62,406 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 05/15/2023 | 26,146 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 04/14/2023 | 27,597 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 03/14/2023 | 23,973 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 03/09/2023 | 40,800 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 03/06/2023 | 23,346 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 02/20/2023 | 390,665 |
Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | 02/20/2023 | 70,815 |
Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | 02/20/2023 | 106,467 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 02/20/2023 | 125,875 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/20/2023 | 74,322 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 12/14/2022 | 559,500 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 12/01/2022 | 22,361 |
O'Connor Donal | Director | 11/22/2022 | 105,000 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 11/20/2022 | 171,473 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 11/20/2022 | 271,868 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 11/18/2022 | 716,242 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/20/2022 | 296,748 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 11/20/2022 | 252,458 |
GRAHAM RICHARD A | SVP, RESEARCH & DEVELOPMENT | 11/16/2022 | 31,360 |
GSK PLC | Former 10% Owner | 09/16/2022 | 94,036,868 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 08/19/2022 | 147,609 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 08/19/2022 | 239,814 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 08/19/2022 | 177,376 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 08/19/2022 | 97,257 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 08/16/2022 | 47,640 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 08/09/2022 | 132,606 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 05/20/2022 | 96,358 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 05/20/2022 | 29,410 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 05/20/2022 | 34,497 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 05/20/2022 | 19,228 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 05/23/2022 | 9,653 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/28/2022 | 23,947 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 02/18/2022 | 218,243 |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | 02/18/2022 | 262,343 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 02/18/2022 | 249,601 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 02/18/2022 | 195,823 |
Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | 02/18/2022 | 113,629 |
BRADY ANN | PRESIDENT, TBIL | 02/18/2022 | 80,426 |
BRADY ANN | PRESIDENT, TBIL | 11/19/2021 | 26,493 |
PASQUALONE FRANK | SVP, CHIEF BUSINESS OFFICER | 11/19/2021 | 31,592 |
PITZER KENNETH R | SVP, PROD STRAT & COMM PLNG | 11/19/2021 | 36,032 |
GRAHAM RICHARD A | SVP, DEVELOPMENT | 11/19/2021 | 35,639 |
Hindman Andrew A. | SVP, CHIEF FINANCIAL OFFICER | 11/19/2021 | 11,286 |
WORBOYS PHILIP D | SVP, RESEARCH & TRANSL SCIENCE | 11/19/2021 | 36,032 |
SABESAN VIJAY | SVP, TECHNICAL OPERATIONS | 11/19/2021 | 43,397 |
Winningham Rick E | CHIEF EXECUTIVE OFFICER | 11/19/2021 | 95,337 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 08/20/2021 | 60,513 |
Winningham Rick E | Chief Executive Officer | 08/20/2021 | 160,226 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2021 | 60,513 |
SABESAN VIJAY | SVP, Technical Operations | 08/20/2021 | 72,962 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2021 | 60,513 |
PASQUALONE FRANK | SVP, Chief Business Officer | 08/20/2021 | 53,095 |
Hindman Andrew A. | SVP, Chief Financial Officer | 08/20/2021 | 245,369 |
GRAHAM RICHARD A | SVP, Development | 08/20/2021 | 95,807 |
BRADY ANN | President, TBIL | 08/20/2021 | 44,524 |
Winningham Rick E | Chief Executive Officer | 05/20/2021 | 202,991 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2021 | 76,718 |
GRAHAM RICHARD A | SVP, Development | 05/20/2021 | 60,698 |
BRADY ANN | President, TBIL | 05/20/2021 | 56,408 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 03/09/2021 | 176,580 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 02/20/2021 | 599,157 |
Winningham Rick E | Chief Executive Officer | 02/20/2021 | 2,073,439 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2021 | 598,819 |
SABESAN VIJAY | SVP, Technical Operations | 02/20/2021 | 156,765 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2021 | 599,984 |
PASQUALONE FRANK | SVP, Chief Business Officer | 02/20/2021 | 506,597 |
Hindman Andrew A. | SVP, Chief Financial Officer | 02/20/2021 | 74,859 |
HAUMANN BRETT K | Chief Medical Officer | 02/20/2021 | 670,277 |
GRAHAM RICHARD A | SVP, Development | 02/20/2021 | 123,958 |
BRADY ANN | President, TBIL | 02/20/2021 | 189,629 |
GRAHAM RICHARD A | SVP, Development | 12/14/2020 | 146,058 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 12/03/2020 | 76,428 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 11/20/2020 | 82,728 |
Winningham Rick E | Chief Executive Officer | 11/20/2020 | 240,011 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2020 | 82,728 |
SABESAN VIJAY | SVP, Technical Operations | 11/20/2020 | 65,364 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2020 | 82,728 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2020 | 72,523 |
HAUMANN BRETT K | Chief Medical Officer | 11/20/2020 | 79,837 |
GRAHAM RICHARD A | SVP, Development | 11/20/2020 | 66,706 |
BRADY ANN | President, TBIL | 11/20/2020 | 39,445 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 08/20/2020 | 87,529 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 08/20/2020 | 307,854 |
Winningham Rick E | Chief Executive Officer | 08/20/2020 | 254,096 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2020 | 87,529 |
SABESAN VIJAY | SVP, Technical Operations | 08/20/2020 | 69,218 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2020 | 87,529 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2020 | 76,779 |
Hindman Andrew A. | SVP, Chief Financial Officer | 08/20/2020 | 78,765 |
HAUMANN BRETT K | Chief Medical Officer | 08/20/2020 | 84,650 |
HAUMANN BRETT K | Chief Medical Officer | 08/21/2020 | 457,240 |
GRAHAM RICHARD A | SVP, Development | 08/20/2020 | 120,216 |
BRADY ANN | President, TBIL | 08/20/2020 | 41,760 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 05/20/2020 | 128,203 |
Winningham Rick E | Chief Executive Officer | 05/20/2020 | 371,940 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2020 | 128,203 |
SABESAN VIJAY | SVP, Technical Operations | 05/20/2020 | 101,373 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2020 | 128,203 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2020 | 112,387 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2020 | 112,334 |
BRADY ANN | President, TBIL | 05/20/2020 | 61,128 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 02/20/2020 | 753,819 |
Winningham Rick E | Chief Executive Officer | 02/20/2020 | 2,508,415 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2020 | 761,512 |
SABESAN VIJAY | SVP, Technical Operations | 02/20/2020 | 186,817 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2020 | 754,622 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 02/20/2020 | 631,753 |
Hindman Andrew A. | SVP, Chief Financial Officer | 02/20/2020 | 182,854 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2020 | 870,447 |
BRADY ANN | President, TBIL | 02/20/2020 | 154,053 |
SABESAN VIJAY | SVP, Technical Operations | 12/12/2019 | 21,598 |
WORBOYS PHILIP D | SVP, Research & Transl Science | 11/20/2019 | 39,987 |
Winningham Rick E | Chief Executive Officer | 11/20/2019 | 152,733 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2019 | 62,779 |
SABESAN VIJAY | SVP, Technical Operations | 11/20/2019 | 25,925 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2019 | 39,987 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2019 | 43,067 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2019 | 47,379 |
BRADY ANN | President, TBIL | 11/20/2019 | 18,885 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2019 | 48,871 |
Winningham Rick E | Chief Executive Officer | 08/20/2019 | 186,664 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2019 | 66,337 |
SABESAN VIJAY | SVP, Technical Operations | 08/20/2019 | 31,663 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2019 | 48,871 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2019 | 50,226 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2019 | 48,871 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2019 | 58,292 |
BRADY ANN | President, TBIL | 08/20/2019 | 23,080 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2019 | 45,076 |
Winningham Rick E | Chief Executive Officer | 05/20/2019 | 172,172 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2019 | 49,362 |
SABESAN VIJAY | SVP, Technical Operations | 05/20/2019 | 29,244 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2019 | 45,076 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2019 | 31,823 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2019 | 45,076 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2019 | 53,667 |
BRADY ANN | President, TBIL | 05/20/2019 | 21,288 |
O'Connor Donal | Director | 05/16/2019 | 27,867 |
O'Connor Donal | Director | 05/17/2019 | 53,968 |
HEGDE SHARATHCHANDRA S | SVP, Research | 03/05/2019 | 139,405 |
HEGDE SHARATHCHANDRA S | SVP, Research | 03/04/2019 | 83,764 |
WORBOYS PHILIP D | SVP, Translational Science | 02/20/2019 | 107,622 |
Winningham Rick E | Chief Executive Officer | 02/20/2019 | 363,879 |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | 02/20/2019 | 155,601 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2019 | 156,546 |
SABESAN VIJAY | SVP, Technical Operations | 02/20/2019 | 123,336 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2019 | 99,198 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 02/20/2019 | 132,813 |
HEGDE SHARATHCHANDRA S | SVP, Research | 02/20/2019 | 101,790 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2019 | 210,006 |
BRADY ANN | President, TBIL | 02/20/2019 | 81,621 |
WORBOYS PHILIP D | SVP, Translational Science | 11/20/2018 | 108,407 |
Winningham Rick E | Chief Executive Officer | 11/20/2018 | 385,658 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2018 | 173,679 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2018 | 96,879 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2018 | 142,171 |
HEGDE SHARATHCHANDRA S | SVP, Research | 11/20/2018 | 100,722 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2018 | 182,653 |
GALA RENEE D | SVP, Chief Financial Officer | 11/20/2018 | 166,019 |
WORBOYS PHILIP D | SVP, Translational Science | 09/12/2018 | 182,201 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/27/2018 | 197,282 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2018 | 148,441 |
Winningham Rick E | Chief Executive Officer | 08/20/2018 | 419,261 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2018 | 188,785 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2018 | 135,909 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2018 | 154,558 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2018 | 140,086 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2018 | 180,107 |
GALA RENEE D | SVP, Chief Financial Officer | 08/20/2018 | 180,430 |
GALA RENEE D | SVP, Chief Financial Officer | 08/15/2018 | 1,110,655 |
GALA RENEE D | SVP, Chief Financial Officer | 08/14/2018 | 61,136 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/08/2018 | 706,182 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/07/2018 | 168,393 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 06/08/2018 | 92,260 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 06/06/2018 | 244,268 |
MALKIEL BURTON G | Director | 05/21/2018 | 22,540 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2018 | 474,628 |
Winningham Rick E | Chief Executive Officer | 05/20/2018 | 1,643,769 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2018 | 530,250 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2018 | 456,517 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2018 | 447,887 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2018 | 464,394 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2018 | 656,151 |
GALA RENEE D | SVP, Chief Financial Officer | 05/20/2018 | 516,101 |
GALA RENEE D | SVP, Chief Financial Officer | 05/18/2018 | 242,877 |
WORBOYS PHILIP D | SVP, Translational Science | 02/20/2018 | 132,825 |
Winningham Rick E | Chief Executive Officer | 02/20/2018 | 378,315 |
SULIMAN SHEHNAAZ | SVP, Corp Dev & Strategy | 02/20/2018 | 255,119 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2018 | 162,526 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2018 | 123,691 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 02/20/2018 | 137,916 |
HEGDE SHARATHCHANDRA S | SVP, Research | 02/20/2018 | 126,512 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2018 | 241,243 |
GALA RENEE D | SVP, Chief Financial Officer | 02/20/2018 | 156,708 |
WORBOYS PHILIP D | SVP, Translational Science | 11/20/2017 | 157,276 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2017 | 202,318 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2017 | 143,300 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 11/20/2017 | 166,336 |
HEGDE SHARATHCHANDRA S | SVP, Research | 11/20/2017 | 147,959 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2017 | 224,239 |
GALA RENEE D | SVP, Chief Financial Officer | 11/20/2017 | 193,001 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 09/06/2017 | 451,350 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/21/2017 | 105,359 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2017 | 150,755 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2017 | 193,965 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2017 | 137,356 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 08/20/2017 | 159,468 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2017 | 141,822 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2017 | 193,554 |
GALA RENEE D | SVP, Chief Financial Officer | 08/20/2017 | 185,005 |
WHITESIDES GEORGE M | Director | 08/11/2017 | 98,764 |
MALKIEL BURTON G | Director | 08/11/2017 | 368,815 |
MALKIEL BURTON G | Director | 08/11/2017 | 368,854 |
Fore Henrietta | Director | 08/11/2017 | 143,932 |
Winningham Rick E | Chief Executive Officer | 08/11/2017 | 245,000 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2017 | 202,676 |
Winningham Rick E | Chief Executive Officer | 05/20/2017 | 569,392 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2017 | 260,720 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2017 | 184,666 |
PASQUALONE FRANK | SVP, Chief Comm Ops Officer | 05/20/2017 | 214,351 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2017 | 190,669 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2017 | 260,204 |
GALA RENEE D | SVP, Chief Financial Officer | 05/20/2017 | 248,713 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 03/07/2017 | 13,059 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 03/06/2017 | 427,916 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 03/03/2017 | 854,772 |
WORBOYS PHILIP D | SVP, Translational Science | 02/20/2017 | 351,211 |
Winningham Rick E | Chief Executive Officer | 02/20/2017 | 1,123,658 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 02/20/2017 | 420,223 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 02/20/2017 | 338,813 |
PASQUALONE FRANK | SVP Global Head Acute Care Bus | 02/20/2017 | 295,980 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2017 | 324,660 |
HEGDE SHARATHCHANDRA S | SVP, Research | 02/20/2017 | 342,462 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 02/20/2017 | 487,581 |
GALA RENEE D | SVP, Chief Financial Officer | 02/20/2017 | 344,928 |
WORBOYS PHILIP D | SVP, Translational Science | 11/20/2016 | 67,244 |
Winningham Rick E | Chief Executive Officer | 11/20/2016 | 267,186 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 11/20/2016 | 128,096 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 11/20/2016 | 55,195 |
LEE JUNNING | Sr. VP, Technical Operations | 11/20/2016 | 120,969 |
HEGDE SHARATHCHANDRA S | SVP, Research | 11/20/2016 | 58,966 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 11/20/2016 | 172,200 |
GALA RENEE D | SVP, Chief Financial Officer | 11/20/2016 | 147,911 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/25/2016 | 125,703 |
WORBOYS PHILIP D | SVP, Translational Science | 08/20/2016 | 58,681 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 08/20/2016 | 48,222 |
LEE JUNNING | Sr. VP, Technical Operations | 08/20/2016 | 105,564 |
HEGDE SHARATHCHANDRA S | SVP, Research | 08/20/2016 | 51,485 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/20/2016 | 128,489 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 08/19/2016 | 265,967 |
GALA RENEE D | SVP, Chief Financial Officer | 08/20/2016 | 120,094 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/20/2016 | 111,783 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/22/2016 | 1,007,038 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/19/2016 | 137,042 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 08/18/2016 | 204,818 |
WORBOYS PHILIP D | SVP, Translational Science | 05/20/2016 | 43,258 |
Shafer Bradford J | EVP, Gen. Counsel, Secretary | 05/20/2016 | 82,364 |
PITZER KENNETH R | SVP, Prod Strat & Comm Plng | 05/20/2016 | 35,510 |
LEE JUNNING | Sr. VP, Technical Operations | 05/20/2016 | 77,782 |
HEGDE SHARATHCHANDRA S | SVP, Research | 05/20/2016 | 37,935 |
HAUMANN BRETT K | SVP Clin Dev & Chief Med Ofc | 05/20/2016 | 94,694 |
GALA RENEE D | SVP, Chief Financial Officer | 05/20/2016 | 68,493 |
GLAXOSMITHKLINE PLC | 10% Owner | 03/14/2016 | 29,959,773,420,000 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2016 | 296,098 |
GALA RENEE D | SVP, Chief Financial Officer | 02/20/2016 | 204,264 |
Mammen Mathai | SVP, Research & Development | 02/20/2016 | 310,559 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2016 | 251,167 |
HAUMANN BRETT K | SVP, Clinical Development | 02/20/2016 | 288,351 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 02/20/2016 | 251,981 |
PASQUALONE FRANK | Sr. VP, Operations | 02/20/2016 | 169,489 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 11/20/2015 | 16,037 |
Mammen Mathai | SVP, Research & Development | 11/20/2015 | 16,037 |
LEE JUNNING | Sr. VP, Technical Operations | 11/20/2015 | 17,805 |
HAUMANN BRETT K | SVP, Clinical Development | 11/20/2015 | 13,410 |
GLAXOSMITHKLINE PLC | 10% Owner | 10/07/2015 | 27,080,666,256 |
Mammen Mathai | SVP, Research & Development | 08/20/2015 | 12,123 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 08/20/2015 | 12,123 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 08/20/2015 | 12,123 |
LEE JUNNING | Sr. VP, Technical Operations | 08/18/2015 | 116,100 |
MALKIEL BURTON G | Director | 08/18/2015 | 129,200 |
GALA RENEE D | SVP, Chief Financial Officer | 08/17/2015 | 60,800 |
GALA RENEE D | SVP, Chief Financial Officer | 08/13/2015 | 60,950 |
Winningham Rick E | Chief Executive Officer | 08/17/2015 | 204,512 |
Winningham Rick E | Chief Executive Officer | 08/14/2015 | 744,421 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 06/02/2015 | 101,789 |
Mammen Mathai | SVP, Research & Development | 06/02/2015 | 101,789 |
LEE JUNNING | Sr. VP, Technical Operations | 06/02/2015 | 71,252 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 06/02/2015 | 101,789 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 05/20/2015 | 9,584 |
LEE JUNNING | Sr. VP, Technical Operations | 05/20/2015 | 10,652 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 05/20/2015 | 9,584 |
Mammen Mathai | SVP, Research & Development | 05/20/2015 | 9,584 |
Shafer Bradford J | Sr VP, Gen. Counsel, Secretary | 02/20/2015 | 13,156 |
Mammen Mathai | SVP, Research & Development | 02/20/2015 | 13,156 |
LEE JUNNING | Sr. VP, Technical Operations | 02/20/2015 | 18,934 |
BLUM LEONARD M | Sr VP, Chief Comm. Officer | 02/20/2015 | 13,156 |
Winningham Rick E | Chief Executive Officer | 02/20/2015 | 28,890 |
GALA RENEE D | SVP-Finance | 08/20/2014 | 4,263 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BAUPOST GROUP LLC/MA | 7,419,226 | 1.82% | No change | Value |
BLACKROCK INC. | 4,587,834 | 0.00131% | 0.46% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 994,000 | 0.00117% | -6.33% | Other |
D. E. SHAW & CO., INC. | 851,208 | 0.00836% | 23.44% | Other |
TUDOR INVESTMENT CORP ET AL | 10,083 | 0.00091% | -90.64% | Event Driven, Other |
ROYCE & ASSOCIATES LP | 59,009 | 0.00613% | No change | Value |
BALYASNY ASSET MANAGEMENT L.P. | 13,699 | 0.00024% | Exited | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View